Loading...
Japanese Trademark — JPO
2024366151
Application 2024366151 · 00
Quick Facts
| Application Number | 2024366151 |
| Registration Number | 1830583 |
| Status | 00 |
| Mark Type | madrid |
| Owner | Atara Biotherapeutics, Inc. |
| Filed | 2024-12-26 |
| Registered | 2024-10-02 |
Is this trademark active?
2024366151 has a current status of 00.
Goods & Services
The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.
Class 5 — Pharmaceuticals
Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders; none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis.
Applicant
| Name (romanised) | Atara Biotherapeutics, Inc. |
Timeline
- Filed: 2024-12-26
- Registered: 2024-10-02
About This Trademark
This device mark (application number 2024366151) is a 00 trademark on the Japan Patent Office register, filed by Atara Biotherapeutics, Inc. on 26 December 2024, with registration granted on 2 October 2024.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations), specifically covering: Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders; none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis.
Frequently Asked Questions
Is Japanese trademark 2024366151 currently a registered trademark?
No — the Japan Patent Office records the status of Japanese trademark 2024366151 as 00.
Which goods or services does Japanese trademark 2024366151 cover?
Japanese trademark 2024366151 is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases an…
When was Japanese trademark 2024366151 filed?
Japanese trademark 2024366151 was filed at the Japan Patent Office on 26 December 2024 and registered on 2 October 2024.
Data Source
Japan (Japan Patent Office)
Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-18.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.